Figure 5
From: Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
Calmodulin levels in plasma from control and Alzheimer’s disease patients. Box plots represent the calmodulin (CaM) concentration in plasma samples from healthy controls and Alzheimer’s disease (AD) patients. Plasma was obtained after blood centrifugation from six control individuals and six AD patients, and CaM levels were measured by enzyme-linked immunosorbent assay. (p = 0.09, two-tailed, unpaired Student’s t test).